With accountability for developing and implementing the Hawaii market integrated strategic plan, I execute strategies to drive improvement in sustainable growth, care transformation, consumer experience, and affordability. I lead teams in operational leadership, performance improvement, strategy consulting, and data analytics in defining objectives, priorities, and standards, oversee the planning and delivery of key strategic initiatives, and closely monitor market, membership, and financial data.Highlights of my contributions include:* Effectively engaging leading tools and best practices to review and optimize organizational processes, promoting continuous improvement* Turning around the Hawaii market to deliver $80M operating income improvement ($2B revenue) and 12K member growth (270K total)* Championing the development of pricing strategies, capital budgeting, and expense reduction initiatives to enhance competitive market positioning across business lines and boost financial performance* Advancing objectives for the improvement of patient outcomes in the timeliness and quality of services while simultaneously reducing costs, implementing 150+ separate initiatives over my tenure* Transforming organizational culture and structure to better align health plan, hospital, and medical group executives in the engagement of strategic direction and prioritization of key initiatives* Integrating $1B ten-year capital planning into master planning to improve cash flow and internal rate of return* Fostering a culture of health and well-being for employees through development, training, and engagement while leading overall people strategy

Leading the development and execution of multi-year growth plans, I engaged strategies to attain financial and membership goals for the HI market. To this effect, I reviewed data analytics and forecasts to refine market positioning and capture growth opportunities, presented strategy recommendations to market and national corporate leaders, and collaborated in the implementation of initiatives for the improvement of care delivery.Highlights of my contributions include:* Embracing multi-year growth strategies to attain targets for commercial coverage among young families in developing communities and expanding offerings in Medicaid/Medicare markets* Aligning revenue and expense targets to drive affordability for large employers and members, delivering consistent year-over-year core rate increases of 2-3%; optimizing investment in key accounts to reposition groups for additional growth* Driving data alignment with enterprise partners to improve efficiency in analytics and reduce forecasting turnaround time

Onboarded to manage internal consulting engagements with senior executives at the enterprise and regional level to: develop and align goals and structure priorities; deliver recommendations on growing market share, improving consumer experience, and increasing profitability while driving affordability; and evaluate investment opportunities.Highlights of my contributions include:* Generating detailed pricing strategies and implementing key initiatives to drive $80B in annual revenues for Northern and Southern CA regions with 9M members, exceeding expectations in financial performance and membership growth* Effectively streamlining the executive review process by synthesizing pricing options, market opportunities, membership projections, and operational performance* Supporting decision making with competitive intelligence and actionable data summaries* Innovating a framework to better analyze market performance across regions, equipping leaders with a tool for enhanced goal definition and metric analysis

Lead Mentor: SQUID iQ, Lana Health, NovaXS BiotechMentor: Relish Life

Establishing this medical device company in partnership with multidisciplinary teams from the Yale schools of management, engineering, and medicine, I influenced business planning to steer processes from concept development to commercialization; maintained relationships among internal teams and external partners to drive core objectives while effectively managing risk; and managed strategic planning as well as product design and development, branding and marketing, and finance.Highlights of my contributions include:* Successfully securing $100K+ in fellowship and grant-based pre-seed funding, and delivering winning pitches to university and state-based innovation fund organizations as well as venture capital and angel investors* Driving the commercialization of a breakthrough novel patented technology offering improved preservation of transplant organs prior to implantation, bringing the technology to market and negotiating licensing with Yale University* Expanding the partner network to include transplant centers and organ banks, gaining key clinical champions* Navigating processes for pre-clinical trials with the use of a functional prototype, managing critical conversations with FDA as well as hospitals and device manufacturers

Recruited to an internal strategy team established to create unique care delivery offerings leveraging newly integrated core of CVS Pharmacy, Caremark, and MinuteClinic. Highlights of my contributions include: * Establishing and launching advanced clinical programs, such as genetic testing, retail clinic copay reduction, hospital readmission prevention, biometric screening, and prescription management in collaboration with cross-functional enterprise partners* Aligning leadership on a holistic approach to assessing the operating income of new offerings, assigning values to each vertical and assessing enterprise-wide impact* Delivering executive support by organizing budgets, creating financial forecasts, articulating value propositions, and developing business cases

Collaborating with top economists and industry experts, I delivered strategy recommendations for complex mergers and acquisitions. I also supported the launch of new products and clinical offerings.Highlights of my contributions include:* Designing financial models, managing market research, and generating summary reports driven by statistical analysis and data visualization* Analyzing economic influence of mergers, acquisitions, and complex litigation to direct strategic recommendations in industries including healthcare, life sciences, finance, and technology